AI breast cancer risk test launches nationwide using mammogram data

A company called Clairity has launched an AI-powered test called Clairity Breast that estimates a woman's risk of developing breast cancer using an existing mammogram image. The test, priced at $249, is now available across the United States.

Unlike traditional risk assessments that rely on family history or genetic testing, this tool analyzes patterns in mammogram imaging directly, aiming to give earlier and more personalized risk information without requiring additional scans or invasive procedures.